Given the following for CME, Inc. CME, Inc. has been in business for 20 years. You are the analyst assigned to value the stock and to make a recommendation to your firm's clients. You research the firm and find out the following information: The firm's CAGR in FCFF projected for the next 3 years (2021, 2022, 2023) to be approximately 6.5%. In 2020, the internal estimate for the annualized FCFF is $12,500. The WACC for the firm is 9.2%. The balance sheet shows cash & marketable securities balance equal to $3,500. Also on the balance sheet, the firm's short-term debt is $1,375 and long term debt is $2.150. The firm has 15,000 shares outstanding. The growth rate in Free Cash Flow is estimated to be 3% forever. Find the following: 1. Enterprise Value 2. Firm Value 3. Equity Value 4. Equity Value per share and 5. The terminal Value Given the following for CME, Inc. CME, Inc. has been in business for 20 years. You are the analyst assigned to value the stock and to make a recommendation to your firm's clients. You research the firm and find out the following information: The firm's CAGR in FCFF projected for the next 3 years (2021, 2022, 2023) to be approximately 6.5%. In 2020, the internal estimate for the annualized FCFF is $12,500. The WACC for the firm is 9.2%. The balance sheet shows cash & marketable securities balance equal to $3,500. Also on the balance sheet, the firm's short-term debt is $1,375 and long term debt is $2.150. The firm has 15,000 shares outstanding. The growth rate in Free Cash Flow is estimated to be 3% forever. Find the following: 1. Enterprise Value 2. Firm Value 3. Equity Value 4. Equity Value per share and 5. The terminal Value